Fructated apolipoprotein A-I showed severe structural modification and loss of beneficial functions in lipid-free and lipid-bound state with acceleration of atherosclerosis and senescence

Biochemical and Biophysical Research Communications

Volumn 392, Issue 3, 2010, Pages 295-300

  Park, Ki Hoon ^a   Jang, Wookju ^a   Kim, Ki Yong ^b   Kim, Jae Ryong ^a   Cho, Kyung Hyun ^a  

^a Yeungnam University   (South Korea)

^b Green Cross Company   (South Korea)

Author keywords

Apolipoprotein A I; Atherosclerosis; Glycation; High density lipoprotein; Senescence

Indexed keywords

APOLIPOPROTEIN A1; HIGH DENSITY LIPOPROTEIN; PHOSPHOLIPID;

ALPHA HELIX; ANTIOXIDANT ACTIVITY; ARTICLE; ATHEROSCLEROSIS; CIRCULAR DICHROISM; CONTROLLED STUDY; ELUTION; FAST PROTEIN LIQUID CHROMATOGRAPHY; FLUORESCENCE ANALYSIS; FRUCTATION; HUMAN; HUMAN CELL; MACROPHAGE; PARTICLE SIZE; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN FUNCTION; PROTEIN GLYCOSYLATION; PROTEIN LIPID INTERACTION; PROTEIN MODIFICATION; PROTEIN STRUCTURE; SENESCENCE; SKIN FIBROBLAST;

AGING; APOLIPOPROTEIN A-I; ATHEROSCLEROSIS; CELL AGING; FIBROBLASTS; FRUCTOSE; GLYCOSYLATION END PRODUCTS, ADVANCED; HUMANS; LIPOPROTEINS, HDL; MACROPHAGES; PROTEIN STRUCTURE, SECONDARY;

EID: 76349119675     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2009.12.179     Document Type: Article

References (29)

1. Tan K.C., Chow W.S., Ai V.H., et al. Advanced glycation end products endothelial dysfunction in type 2 diabetes. Diabetes Care 25 (2002) 1055-1059
2. Kilhovd B.K., Juutilainen A., Lehto S., et al. High serum levels of advanced glycation end products predict increased coronary heart disease mortality in nondiabetic women but not in nondiabetic men: a population-based 18-year follow-up study. Arterioscler. Thromb. Vasc. Biol. 25 (2005) 815-820
3. Curtiss L.K., and Witztum J.L. Apolipoproteins AI, AII, B, CI, and E are glucosylated in hyperglycemic diabetic subjects. Diabetes 34 (1985) 452-461
4. Bantle J.F. Dietary fructose and metabolic syndrome and diabetes. J. Nutr. 139 (2009) 1263S-1268S
5. Boguski M.S., Freeman M., and Elshourbagy N.A. On computer-assisted analysis of biological sequences: proline punctuation, consensus sequences, and apolipoprotein repeats. J. Lipid Res. 27 (1986) 1011-1034
6. Ferretti G., Bacchetti T., Negre-Salvayre A., et al. Structural modifications of HDL and functional consequences. Atherosclerosis 184 (2006) 1-7
7. Sviridov D. Maturation of apolipoprotein A-I: unrecognized health benefit or a forgotten rudiment. J. Lipid Res. 50 (2009) 1257-1258
8. Lee H.S., Sen L.C., Clifford A.J., et al. Preparation and nutritional properties of caseins covalently modified with sugars. reductive alkylation of lysines with glucose, fructose, or lactose. J. Agric. Food Chem. 27 (1979) 1094-1098
9. Segrest J.P., Li L., Anantharamaiah G.M., et al. Structure and function of apolipoprotein A-I and high-density lipoprotein. Curr. Opin. Lipidol. 11 (2000) 105-115
10. Passarelli M., Tang C., McDonald T.O., et al. Advanced glycation end product precursors impair ABCA1-dependent cholesterol removal from cells. Diabetes 54 (2005) 2198-2205
11. Brewer H.B., Ronan R., Meng M., et al. Isolation and characterization of apolipoprotein A-I, A-II, and A-IV. Meth. Enzymol. 28 (1986) 223-246
12. Pongor S., Ulrich P.C., Bencsath F.A., et al. Aging of proteins: isolation and identification of a fluorescent chromophore from the reaction of polypeptides with glucose. Proc. Natl. Acad. Sci. USA 81 (1984) 2684-2688
13. Markwell M.A., Haas S.M., and Bieber L.L. A modification of the Lowry procedure to simplify protein determination in membrane and lipoprotein samples. Anal. Biochem. 87 (1978) 206-210
14. Chen P.S., Toribara T.Y., and Warner H. Microdetermination of phosphorus. Anal. Chem. 28 (1956) 1756-1758
15. Heider J.G., and Boyett R.L. The picomole determination of free and total cholesterol in cells in culture. J. Lipid Res. 19 (1978) 514-518
16. Davidson W.S., Hazlett T., Mantulin W.W., et al. The role of apolipoprotein AI domains in lipid binding. Proc. Natl. Acad. Sci. USA 93 (1996) 13605-13610
17. Chen Y.H., Yang J.T., and Martinez H.M. Determination of the secondary structures of proteins by circular dichroism and optical rotatory dispersion. Biochemistry 11 (1972) 4120-4131
18. Blois M.S. Antioxidant determinations by the use of a stable free radical. Nature 181 (1958) 1199-1200
19. Esterbauer H., Striegl G., Puhl H., et al. Continuous monitoring of in vitro oxidation of human low density lipoprotein. Free Radic. Res. Commun. 6 (1989) 67-75
20. Kim H.J., Kim K.S., Kim S.H., et al. Induction of cellular senescence by secretory phospholipase A2 in human dermal fibroblasts through an ROS-mediated p53 pathway. J. Gerontol.:Biol Sci. 64A (2009) 351-362
21. Cho K.H. Synthesis of reconstituted high-density lipoprotein (rHDL) containing apoA-I and apoC-III: the functional role of apoC-III in rHDL. Mol. Cells 27 (2009) 291-297
22. Dimri G.P., Lee X., Basile G., et al. A biomarker that identifies senescent human cells in culture and in aging skin in vivo. Proc. Natl. Acad. Sci. USA 92 (1995) 9363-9367
23. Nofer J.R., Walter M., and Assmann G. Current understanding of the role of high-density lipoproteins in atherosclerosis, senescence. Expert Rev. Cardiovasc. Ther. 3 (2005) 1071-1086
24. Scarmeas N. Invited commentary: lipoproteins and dementia-is it the apolipoprotein A-I?. Am. J. Epidemiol. 165 (2007) 993-997
25. Barzilai N., Atzmon G., Schechter C., et al. Unique lipoprotein phenotype and genotype associated with exceptional longevity. J Am. Med. Assoc. 290 (2003) 2030-2040
26. Pu D.R., and Liu L. HDL slowing down endothelial progenitor cells senescence. A novel anti-atherogenic property of HDL. Med. Hypotheses 70 (2008) 338-342
27. Nobercurt E., Davies M.J., Brown B.E., et al. The impact of glycation on apolipoprotein A-I structure and its ability to activate lecithin:cholesterol acyltransferase. Diabetologia 50 (2007) 643-653
28. Hoang A., Murphy A.J., Coughlan M.T., et al. Advanced glycation of apolipoprotein A-I impairs its anti-atherogenic properties. Diabetologia 50 (2007) 1770-1779
29. Hedrick C.C., Thorpe S.R., Fu M.X., et al. Glycation impairs high-density lipoprotein function. Diabetologia 43 (2000) 312-320